EULAR QoC Ongoing Initiatives
 
  • QoC047 (NON TF) - EULAR HARMONY-RHEUM initiative: Harmonizing Terminology in Rheumatology to Improve Communication and Quality of Care (non - task force project)
    U. Kiltz / G. Fragoulis / X. Baraliakos   

  • QoC046 (IMPL) - AIRA - Assessment, Intervention and Re-Assessment of the ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update, IMPLEMENTATION PROJECT
    K. Schreiber / S. Ramiro

  • QoC045 - Development of EULAR recommendations for cardiorespiratory fitness in people with Rheumatic and Musculoskeletal Diseases
    T. WillemSwinnen / K. Nordén
     
  • QoC044 - EAR / ERA recommendations for the management of ANCA-associated vasculitis: 2027 update
    B. Hellmich / D. Jayne  

  • QoC043 - EULAR points to consider for the diagnosis and management of IgG4-related disease
    U. Kiltz / E. Della Torre   

  • QoC042 -  EULAR recommendations for the management of idiopathic inflammatory myopathies in adult
    P. Machado / I. Lundberg
           
  • QoC041 - Update of EULAR Recommendations for the Management of Fibromyalgia
    Gary Macfarlane 

  • QoC040 - Points to consider: Use of CAR-based therapies and T cell engagers in inflammatory rheumatic diseases
    M. Scherlinger / J. Avouac 

  • QoC039 -  Update of the EULAR points to consider/recommendations for the use of Artificial Intelligence and Big Data in RMDs
    G. Burmester / L. Gupta 

  • QoC038 (IMPL) - Implementing the updated EULAR recommendations for patient research partner involvement in research: the INSPIRE initiative (Implementing New Strategies for PRP Involvement in Research at EULAR), IMPLEMENTATION PTOJECT
    Muriel Elhai / Krystel Aouad

  • QoC037 -  EULAR recommendations for the management of gout: 2027 update
    Abhishek Abhishek / Richette Pascal

  • QoC036 (NON TF) - AI-Driven Screening: Evaluating ASReview for SLRs informing EULAR recommendations/points-to-consider
    Sofia Ramiro / Philipp Bosch

  • QoC035 (IMPL) - Piloting a Pragmatic Dissemination and Early Implementation Model for EULAR Recommendations/Points to Consider, IMPLEMENTATION PROJECT
    Fernando Estevez Lopez / Nina Østerås

  • QoC034 -  EULAR-ACR Development and Validation of a Revised Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies
    Ingrid Lundberg (EULAR) / Rohit Aggarwal (ACR) 
     
  • QoC033 - Update of the EULAR Recommendations for Cardiovascular Risk Management in Patients with Rheumatic and Musculoskeletal Diseases
    Mike Nurmohamed / Maria Tektonidou 

  • QoC032 - EULAR recommendations for the assessment of malignancy risk in autoimmune rheumatic diseases
    Elena Nikiphorou

  • QoC031 - EULAR points to consider on the combination of targeted therapies in patients with inflammatory arthritis or systemic autoimmune rheumatic diseases
    J.E. Gottenberg / T. Pham

  • QoC030 - 202X update of the EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
    Hendrik Schulze/ Koops / Jacques E. Gottenberg

  • QoC029 (IMPL) - EULAR Plan for the Implementation of Recommendations 2024-25, IMPLEMENTATION PROJECT
    Krysia Dziedzic (Keele University group)

  • QoC028 - 2025 Update of the EULAR Recommendation for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice
    Peter Mandl / Mikkel Østergaar

  • QoC026 - EULAR recommendations for the screening and management of osteoporosis in patients with inflammatory rheumatic musculoskeletal diseases (iRMDs)
    Frank Buttgereit / Giovanni Adami

  • QoC024 - 2024 Update on Vaccination Recommendations for Patients with Autoimmune Inflammatory Rheumatic Diseases
    Ori Elkayam / Ulf Mueller Ladner

  • QoC021 - Update of the EULAR recommendations for patient education in people with inflammatory rheumatic and musculoskeletal diseases including recommendations for implementation into clinical practice
    Jet Veldhuijzen van Zanten / Catherine Beauvais

  • QoC017 - EULAR Points to Consider on risk stratification of populations for RA prevention studies: new inclusion of ACR collaboration and population-based approaches to risk stratification
    Kevin Deane / Kulveer Mankia/ A. Van der Helm / Karim Raza

  • QoC014 - ACR-EULAR Development of Classification Criteria for Immune Related Adverse Events: Inflammatory Arthritis
    A.Meara / M.Kostine

  • QoC004 - Development of EULAR/ACR Criteria for Disease Activity and Response in Giant Cell Arteritis
    Dejaco / Langford 

  • CLI108 - EULAR-ACR Classification Criteria for Antisynthetase Syndrome (CLASS)
    Aggarwal Rohit (ACR) / Cavagna Lorenzo (EULAR)

  • CLI098 - ACR-EULAR Criteria for Treatment Response for ANCA‐Associated Vasculitis
    Peter Merkel / Gunnar Tomasson

  • CLI088 - The Development of New Classification Criteria for Hand Osteoarthritis
    Margreet Kloppenburg

  • IMG013 - EULAR Recommendations for the use of imaging in patient with mechanical back pain
    Gilles Fournier
 
Application for Project Grants

EULAR welcomes project applications from rheumatologists across Europe designed for developing EULAR Recommendations, EULAR Criteria, EULAR Points to Consider, or similar projects.

See more

EULAR Recommendations

The EULAR Committees regularly establish and publish recommendations for the treatment of various rheumatic disorders. Each of these recommendations are developed by a Task Force of specialists in their field.

See more